Table 1. Clinical and pathological stage.
Clinical stage | Patients |
---|---|
cT1c N0/N× M0 | 38 (73.1%) |
cT2a N0/N× M0 | 8 (15,4%) |
cT2b N0/N× M0 | 3 (5.8%) |
cT2c N0/N× M0 | 1 (1.9%) |
cT3b N0/N× M0 | 2 (3.8%) |
Patological stage | Patients |
pT2a N0 M0 | 14 (26.9%) |
pT2b N0 M0 | 20 (38.5%) |
pT2c N0 M0 | 8 (15.4%) |
pT3a N0 M0 | 5 (9.6%) |
pT3b N0 M0 | 4 (7.7%) |
pT3b N1 M0 | 1 (1.9%) |
Pathological Gleason score | Patients |
Gleson 6 | 22 (42.3%) |
Gleason 7 (3+4) | 18 (34.6%) |
Gleason 7 (4+3) | 10 (19.2%) |
Gleason 8 | 2 (3.9%) |